The billionaire investor Carl Icahn is not a fan of Cigna's plan to purchase the pharmacy benefit manager Express Scripts, a $67 billion deal that was announced in March. In a letter to Cigna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results